Anaesthesia and Intensive Care, Vol. 35, No. 6, December 2007 Hospital and Medical Center, a tertiary academic medical centre affiliated with State University of New York, Brooklyn, U.S.A. The inclusion criteria included septic shock patients on vasopressors. The definition of septic shock was in accordance with current guidelines 12 . The exclusion criteria included history of malignancy, past use of chemotherapeutic drugs, a history of platelet disorders, mechanical cardiac valves, splenectomy or hypersplenism, alcohol abuse, other causes of shock except sepsis and septic patients who were not in shock.
Detailed medical history, physical examination, complete blood counts, biochemistry panel, arterial lactate and serum cortisol were determined in all patients within 24 hours of admission or onset of septic shock as per the ICU protocol. We used three well-established scoring systems to estimate the clinical prognosis and organ dysfunction in our study: APACHE II score 13 , LOD score 14 and SOFA score 15 , which were determined in all patients at admission or onset of septic shock. Thrombocytopenia was defined as platelet count <150×10 9 /l, the lower limit of platelet count in our clinical laboratory. We classified patients into various grades of severity according to the degree of thrombocytopenia: mild=101-149×10 9 /l, moderate=51-100×10 9 /l, severe=21-50×10 9 /l and very severe=<20×10 9 /l 15 . Other data collected at admission included age, source of sepsis, use of medications including frusemide, heparin and beta-lactam antibiotics, presence of bacteraemic sepsis, P a o 2 /FiO 2 ratio and use of mechanical ventilation. A consultant haematologist determined the causes of thrombocytopenia in the study group after evaluation of potential causes like sepsis, medications, DIC (defined as the presence of elevated D-dimers and a ≥25% reduction in two of the following markers: prothrombin time, antithrombin, fibrinogen level and platelet count within 24 hours) and antiplatelet factor 4-heparin antibodies in cases suspicious of heparin-induced thrombocytopenia. We followed the patients until they died or for six months to determine the mortality rate. Major bleeding episodes were recorded for each patient, including life-threatening episodes, and those compromising haemodynamic status or requiring transfusions. The study was approved by the Institutional Review Board of the hospital. We did not take informed consent as the study was merely observational and did not deviate from the usual standards of ICU care of septic shock patients. was done to compare the two survival curves. Hazard ratio for predicting increased mortality by platelet count was calculated using Kaplan-Meier survival analysis. All P values were two-sided and were considered significant at ≤0.05.
STATISTICAL ANALYSIS

RESULTS
We studied 69 septic shock patients with a mean age of 66.2 years (95% confidence interval=62.5-69.9, range=24 to 95 years). Major sources for sepsis included pneumonia (26 patients), urinary tract infection (16 patients), skin/decubitus (nine patients), intra-abdominal (five patients), central nervous system infection (three patients) and unknown source (10 patients). The characteristics of the study patients are demonstrated in Table 1 .
Thrombocytopenia was present in 38 (55%) patients. The distribution of patients into various grades of severity of thrombocytopenia is shown in Table 1 . Table 2 shows the causes of thrombocytopenia in the study group. Table 3 shows the comparison of clinical data in patients with and without thrombocytopenia. Patients with thrombocytopenia had significantly higher serum creatinine, SOFA score and vasopressor requirement as well as lower P a o 2 /FiO 2 ratio (P <0.05). Patients with thrombocytopenia also had higher mortality rate compared with patients without thrombocytopenia (71% vs. 35.5%, P=0.001).
The risk factors associated with thrombocytopenia in septic shock according to multivariate logistic regression analysis are demonstrated in Table 4 . Higher SOFA score, low P a o 2 /FiO 2 ratio and high vasopressor dose were independent risk factors for development of thrombocytopenia after adjusting for age and gender. Presence of renal failure (as measured by serum creatinine), serum albumin, LOD score, APACHE II score and use of heparin, frusemide and beta-lactam antibiotics were not independent risk factors for development of thrombocytopenia after adjusting for age and gender. The presence of thrombocytopenia had significant correlation with SOFA score (r=-0.32, P=0.008) as shown in Figure 1 , but had no significant correlation (Area under curve=0.56, 95% confidence interval=0.43-0.68). Flat line shows a factor which has no effect on mortality.
Curves falling above the flat line are predictive of increased mortality. with APACHE II score (r=-0.09, P=0.47), LOD score (r=-0.004, P=0.97) and number of ICU days (r=-0.07, P=0.54). On ROC curve analysis, platelet count was found to be predictive of increased mortality (area under curve=0.56, 95% confidence interval=0.43-0.68) as shown in Figure 2 . A platelet count of <95×10 9 /l had a sensitivity of 39.5% and specificity of 77.4% in predicting increased mortality as demonstrated in Figure 3 on ROC curve analysis. Kaplan-Meier survival analysis ( Figure 4 ) showed that thrombocytopenic patients had 1.4 times increased risk of mortality (hazard ratio=1.4, 95% confidence interval=0.72-2.95) and lower survival probability at six months (log rank test P=0.03). Five patients (7.2%) had bleeding at some time during their ICU stay, requiring packed red cell transfusion.
DISCUSSION
Our study results demonstrate that thrombocytopenia is common in septic shock and sepsis is the major causative factor. Higher SOFA score, low P a o 2 /FiO 2 ratio and high vasopressor dose are independent risk factors for development of thrombocytopenia. Patients with thrombocytopenia had worse clinical outcome determined by higher serum creatinine, SOFA score, vasopressor requirement, lower P a o 2 /FiO 2 ratio and increased mortality.
The incidence of thrombocytopenia was 55% in our study patients. This incidence is higher than that reported in previous studies which have reported an incidence of 23 to 27% in ICU patients 7, 16 , up to 41% in trauma patients 17 and 35 to 58% in patients with sepsis or septicaemia 18, 19 . This could be explained by the reason that our study population was more critically ill as we included only patients with septic shock. This variation could also be explained by different definitions of thrombocytopenia (platelet counts <100×10 9 /l, <150×10 9 /l or <200×10 9 /l) to that used in some previous studies.
Thrombocytopenia in septic shock has various contributing causes. Various mechanisms have been given to explain the effect of sepsis on platelet count as explained earlier [1] [2] [3] [4] [5] [6] [7] [8] . In our study we found that sepsis was the most contributing factor for thrombocytopenia. Sepsis was also the major independent risk factor for thrombocytopenia in another study 1 . Medications contributed to only 13% cases of thrombocytopenia while no case of heparininduced thrombocytopenia was found in our study.
We found that higher SOFA score, low P a o 2 /F i O 2 ratio and high vasopressor dose were independent risk factors for development of thrombocytopenia after adjusting for other factors. Presence of renal failure (as measured by serum creatinine), serum albumin, LOD score, APACHE II score and use of heparin, frusemide and beta-lactam antibiotics were not independent risk factors for development of thrombocytopenia after adjusting for age and gender. A previous study also found that sepsis and elevated creatinine level were independent risk factors for severe thrombocytopenia 7 . Heparin use was not a significant risk factor for thrombocytopenia in other studies as well 7, 20 . Beta-lactam antibiotics were not an independent risk factor for development of thrombocytopenia in our study. This finding is also supported by other studies 1, 16, 17, 20 .
Since drug-induced thrombocytopenia represents only a minority of such cases in the ICU, it has been suggested that clinicians should regard evolving thrombocytopenia in critically ill patients as an early warning sign of sepsis, rather than attributing it to medications 21 .
We found that septic shock patients with thrombocytopenia at admission or onset of septic shock had significantly higher serum creatinine, SOFA score, vasopressor requirement as well as lower P a o 2 /F i O 2 ratio. Patients with thrombocytopenia also had higher mortality rate compared to patients without thrombocytopenia. On ROC curve analysis, platelet count was found to be predictive of increased mortality. Platelet count of <95×10 9 /l had a sensitivity of 39% and specificity of 77% in predicting increased mortality. Thrombocytopenic patients also had 1.4 times increased risk of mortality and lower predicted survival at six months on Kaplan-Meier survival analysis. This is the first study exploring the clinical outcome of thrombocytopenic septic shock patients to the best of our knowledge. Thrombocytopenia has been found to be an independent marker for mortality in previous studies in critically ill medical or surgical patients 7-11 and correlates with a prolonged ICU stay, more bleeding and worse survival 1,7 . However, thrombocytopenia appears to be an early marker and not a causative factor for increased mortality as apparent by the low bleeding incidence in our study patients. It appears that thrombocytopenia is a manifestation of the severity of underlying septic process, which contributes to increased mortality. Correction of the underlying septic process is therefore paramount in correcting thrombo-cytopenia.
In conclusion, this is the first study of incidence, risk factors for development of thrombocytopenia and clinical outcome in thrombocytopenic patients in the subgroup of septic shock patients in the ICU.
Thrombocytopenia is common in this subgroup and is associated with worse clinical outcome. Thus, thrombocytopenia at admission or at onset of septic shock in septic shock patients can be used as an early marker for risk stratification to identify patients at risk of complicated clinical course and increased mortality. Clinicians should be aggressive in diagnosing and treating the cause of thrombocytopenia in septic shock patients in view of their poor clinical outcome.
